
CRISPR biotech Caribou Biosciences’ IPO reels in $304M for next-gen cell therapy
Caribou Biosciences’ CRISPR approach to cell therapy sparked strong investor interest, enabling the clinical-stage biotech to upsize its IPO and raise $304 million in the […]